CAR-T Cell Immunotherapy in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma

Name: CAR-T Cell Immunotherapy in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma
License: Public Domain

PersonGen BioTherapeutics (Suzhou) Co., Ltd.

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

acute lymphocytic leukemia, chronic lymphocytic leukemia, follicular lymphoma, mantle cell lymphoma, b-cell prolymphocytic leukemia, diffuse large cell lymphoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 217021
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.